{
  "experiment": "Exp 20: Epigenetic Vulnerability Mapping",
  "epigenetic_families": 9,
  "total_genes_tested": 93,
  "pan_cancer_landscape": {
    "most_essential": [
      {
        "gene": "KAT8",
        "family": "HAT",
        "mean_effect": -1.655143666490545,
        "essential_fraction": 0.9990791896869244
      },
      {
        "gene": "RBBP4",
        "family": "PRC2",
        "mean_effect": -1.327661285420923,
        "essential_fraction": 0.998158379373849
      },
      {
        "gene": "ACTL6A",
        "family": "SWI_SNF",
        "mean_effect": -1.4977969562116096,
        "essential_fraction": 0.9861878453038674
      },
      {
        "gene": "SETD1A",
        "family": "KMT",
        "mean_effect": -0.9589933508699822,
        "essential_fraction": 0.9659300184162063
      },
      {
        "gene": "BRD4",
        "family": "BET",
        "mean_effect": -1.0121325827308718,
        "essential_fraction": 0.932780847145488
      }
    ]
  },
  "cancer_specific": {
    "total_tests": 0,
    "significant_fdr05": 0,
    "lineages_tested": 0
  },
  "rewiring": {
    "total_tests": 128,
    "significant_fdr05": 25
  },
  "druggable_targets": [
    {
      "gene": "BRD4",
      "drug": "JQ1/OTX015/ABBV-075 (clinical trials)",
      "pan_cancer_essential_frac": 0.932780847145488
    },
    {
      "gene": "DNMT1",
      "drug": "Azacitidine/Decitabine (FDA)",
      "pan_cancer_essential_frac": 0.7596685082872928
    },
    {
      "gene": "EHMT2",
      "drug": "UNC0642 (preclinical)",
      "pan_cancer_essential_frac": 0.36095764272559855
    },
    {
      "gene": "EP300",
      "drug": "CCS1477 (clinical trial)",
      "pan_cancer_essential_frac": 0.22467771639042358
    },
    {
      "gene": "CREBBP",
      "drug": "A-485 (preclinical)",
      "pan_cancer_essential_frac": 0.07366482504604052
    },
    {
      "gene": "DOT1L",
      "drug": "Pinometostat (clinical trial)",
      "pan_cancer_essential_frac": 0.05432780847145488
    },
    {
      "gene": "EZH2",
      "drug": "Tazemetostat (FDA approved)",
      "pan_cancer_essential_frac": 0.040515653775322284
    },
    {
      "gene": "SMARCA2",
      "drug": "FHD-286 (clinical trial)",
      "pan_cancer_essential_frac": 0.03406998158379374
    },
    {
      "gene": "HDAC1",
      "drug": "Vorinostat/Romidepsin (FDA)",
      "pan_cancer_essential_frac": 0.027624309392265192
    },
    {
      "gene": "BRD9",
      "drug": "BI-7273 (preclinical)",
      "pan_cancer_essential_frac": 0.013812154696132596
    },
    {
      "gene": "KDM1A",
      "drug": "Iadademstat (clinical trial)",
      "pan_cancer_essential_frac": 0.007366482504604052
    },
    {
      "gene": "KDM5B",
      "drug": "KDOAM-25 (preclinical)",
      "pan_cancer_essential_frac": 0.0027624309392265192
    },
    {
      "gene": "HDAC6",
      "drug": "Ricolinostat",
      "pan_cancer_essential_frac": 0.0
    },
    {
      "gene": "DNMT3A",
      "drug": "Azacitidine",
      "pan_cancer_essential_frac": 0.0
    }
  ]
}